What Are Cough-Variant Asthma Symptoms and Treatments?
At a Glance
Cough-variant asthma causes a persistent dry cough, often worse at night or with exercise, without typical wheezing. Diagnosis uses breathing tests and may require a methacholine challenge; daily anti-inflammatory inhalers are the main treatment.
In this answer
3 sections
A chronic, nagging dry cough (typically defined in adults as lasting more than 8 weeks) has many possible causes and requires a medical evaluation. However, when a persistent dry cough is the primary or only symptom of asthma, without classic wheezing, it is called cough-variant asthma (CVA) [1][2]. Because people with CVA do not usually wheeze, the condition can easily be mistaken for a lingering cold [1].
When to Seek Immediate Care:
Seek emergency medical care if you experience severe or rapidly worsening breathing difficulty, inability to speak in full sentences, blue or gray lips, severe chest pain, or a poor response to your prescribed reliever inhaler. Promptly see a doctor if you are coughing up blood, have unexplained weight loss, or have a high fever.
Symptoms of Cough-Variant Asthma
In cough-variant asthma, the airways are overly sensitive and inflamed. You might notice the following symptom patterns:
- Nighttime worsening: The cough is often most bothersome at night, frequently waking you from sleep [1].
- Specific triggers: The cough tends to flare up during or after exercise, or when you are exposed to cold air, smog, dust, strong fragrances, and other irritants [1].
- Dry and persistent: The cough is usually dry (unproductive of mucus) and persists long after a typical viral illness should have resolved [2].
How is it Diagnosed?
Diagnosing CVA requires objective testing and ruling out other causes, as symptoms alone cannot confirm it.
- Spirometry: This standard breathing test measures lung function. In people with CVA, the baseline results are often normal or near normal [3].
- Bronchodilator Test: Testing to see if the cough improves after taking a reliever medicine can support the diagnosis, but a lack of immediate improvement does not rule out CVA [4][5].
- Methacholine Challenge: If spirometry is normal, doctors may use a bronchoprovocation test. Under close medical supervision, you inhale a mist that temporarily provokes sensitive airways to constrict. A positive result demonstrates airway hyperresponsiveness. While this result strongly supports a CVA diagnosis when combined with your symptoms, it is not uniquely diagnostic on its own [3][6].
- Inflammation Biomarkers: Your doctor might measure FeNO (fractional exhaled nitric oxide) or examine a sputum sample to look for allergic inflammation. These tests help build the case for CVA but cannot confirm or exclude it on their own [7][4].
Your doctor will also evaluate you for other common causes of a chronic cough. These include upper-airway cough syndrome (postnasal drip from allergies), acid reflux (GERD), smoking or vaping, side effects from blood pressure medications (like ACE inhibitors), and nonasthmatic eosinophilic bronchitis (a condition with airway inflammation but no airway hyperresponsiveness) [8][9][10].
Treatment and Management
Cough-variant asthma is treated with daily controller medications to reduce the underlying inflammation in your airways.
- Inhaled Corticosteroids (ICS): A daily ICS is generally the cornerstone of initial treatment [4]. Depending on your severity and the clinical guidelines your doctor follows, you may be prescribed an ICS alone or a combination inhaler containing an ICS and a Long-Acting Beta-Agonist (LABA) [4][11]. (Note: A LABA should never be used without an ICS).
- Alternative Medications: Other treatments, such as leukotriene modifiers (like montelukast), may also improve the cough [11]. However, montelukast carries an FDA boxed warning for serious neuropsychiatric side effects, including mood, behavior, or sleep changes. Contact your doctor promptly if you notice these changes, and do not start or stop this medication on your own.
What to expect during treatment:
- Timeline for Improvement: Unlike wheezing, which may respond quickly to a reliever inhaler, a chronic asthma cough takes time to heal. It can take several weeks of consistent daily controller use to see significant improvement, and some patients see continued gradual improvement over a few months [12]. However, if your symptoms worsen or fail to improve, contact your doctor sooner rather than waiting.
- Follow-up: Your doctor will likely schedule a follow-up appointment within a few weeks of starting treatment to check your progress, ensure your inhaler technique is correct, and verify the diagnosis [4].
- Safety and Adherence: Always follow your personalized asthma action plan. To prevent oral thrush, rinse your mouth with water and spit after using an ICS. Never abruptly stop your controller medication without your doctor’s supervision, even if your cough disappears, as stopping early can cause the inflammation and cough to return [13].
Common questions in this guide
What is cough-variant asthma, and how is it different from typical asthma?
What symptoms can suggest cough-variant asthma?
How do doctors diagnose cough-variant asthma?
What treatments are used for cough-variant asthma?
How long does it take for cough-variant asthma treatment to work?
When should I seek urgent care for a cough or breathing symptoms?
Related questions
Get notified when new evidence is published on asthma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (13)
- 1
Cough-Variant Asthma: A Review of Clinical Characteristics, Diagnosis, and Pathophysiology.
Cox JK, Lockey R, Cardet JC
The journal of allergy and clinical immunology. In practice 2025; (13(3)):490-498 doi:10.1016/j.jaip.2024.11.005.
PMID: 39557293 - 2
Cough variant asthma.
Niimi A
Nihon rinsho. Japanese journal of clinical medicine 2016; (74(10)):1693-1697.
PMID: 30551282 - 3
Pearls and pitfalls in the diagnosis of cough variant asthma.
Corrao WM
Allergy and asthma proceedings 2018; (39(6)):466-467 doi:10.2500/aap.2018.39.4168.
PMID: 30401324 - 4
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2025; (48(3)):208-248 doi:10.3760/cma.j.cn112147-20241013-00601.
PMID: 40050074 - 5
Prediction of bronchodilation test in adults with chronic cough suspected of cough variant asthma.
Hao H, Pan Y, Xu Z, et al.
Frontiers in medicine 2022; (9()):987887 doi:10.3389/fmed.2022.987887.
PMID: 36569143 - 6
The Value of Body Plethysmography (sGaw) in the Assessment of Airway Hyperreactivity in Cough Variant Asthma.
Karamarkovic Lazarusic N, Popovic-Grle S, Tolic E, et al.
Journal of clinical medicine 2024; (14(1)) doi:10.3390/jcm14010074.
PMID: 39797163 - 7
A Comparative Study of Type 2 Inflammatory Biomarkers Combined with Small Airway Parameters for Diagnosing Cough-Variant Asthma.
Ondo Osie EMM, Bai H, Liu J, et al.
Journal of asthma and allergy 2026; (19()):609152 doi:10.2147/JAA.S609152.
PMID: 42222523 - 8
Narrative Review: how long should patients with cough variant asthma or non-asthmatic eosinophilic bronchitis be treated?
Niimi A
Journal of thoracic disease 2021; (13(5)):3197-3214 doi:10.21037/jtd-20-2026.
PMID: 34164212 - 9
The Predicative Clinical Features Associated with Chronic Cough That Has a Single Underlying Cause.
Lai K, Zhan W, Li H, et al.
The journal of allergy and clinical immunology. In practice 2021; (9(1)):426-432.e2 doi:10.1016/j.jaip.2020.06.066.
PMID: 32693212 - 10
The Korean Cough Guideline: Recommendation and Summary Statement.
Rhee CK, Jung JY, Lee SW, et al.
Tuberculosis and respiratory diseases 2016; (79(1)):14-21 doi:10.4046/trd.2016.79.1.14.
PMID: 26770230 - 11
Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma.
Yi F, Zhan C, Liu B, et al.
Respiratory research 2022; (23(1)):279 doi:10.1186/s12931-022-02114-6.
PMID: 36217131 - 12
[A multicenter, prospective, observational study of cough variant asthma in China: clinical features, airway inflammation, and prognosis].
Lai KF, Zhan WZ, Jiang ZY, et al.
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2025; (48(11)):1009-1019 doi:10.3760/cma.j.cn112147-20250402-00180.
PMID: 41218858 - 13
Retrospective, observational study of different medication regimens and outcome in children with cough variant asthma.
Lou N, Ma X, Luo Q, et al.
Immunity, inflammation and disease 2024; (12(8)):e1357 doi:10.1002/iid3.1357.
PMID: 39110093
This page is for informational purposes only and does not constitute medical advice. A clinician should evaluate a persistent cough and guide any inhaler or medication changes.